In ovarian, head and neck, and pancreatic cancers, the expression of NKR ligands B7-H6, ULBP2, RAET1E, and death receptor TRAIL-R were associated with a poorer prognosis [61,63,64]. This evidence concerns the gene RAET1E and pancreatic neoplasm.